Literature DB >> 26970242

A new eosinophilic esophagitis (EoE)-like disease without tissue eosinophilia found in EoE families.

A Straumann1, C Blanchard2, S Radonjic-Hoesli3, Ch Bussmann4, P Hruz5, E Safroneeva6, D Simon7, A M Schoepfer8, H-U Simon3.   

Abstract

BACKGROUND: Eosinophilic esophagitis (EoE) is a rapidly emerging, chronic inflammatory, genetically impacted disease of the esophagus, defined clinically by symptoms of esophageal dysfunction and, pathologically, by an eosinophil-predominant tissue infiltration. However, in four EoE families, we have identified patients presenting with EoE-typical and corticosteroid-responsive symptoms, but without tissue eosinophilia. The aim of this study was to clinically and immunologically characterize these patients with EoE-like disease.
METHODS: Five patients suffering from an EoE-like disease were evaluated with endoscopic, histologic, functional, and quantitative immunohistological examinations, and mRNA expression determination.
RESULTS: The frequency of first-generation offspring of patients affected by EoE or EoE-like disease was 40%. Immunofluorescence analysis confirmed an almost complete absence of eosinophils in the esophageal tissues of patients with EoE-like disease, but revealed a considerable T-cell infiltration, comparable to EoE. In contrast to EoE, eotaxin-3 mRNA and protein were markedly reduced in EoE-like disease (P < 0.05). The mRNA expression levels of three selected EoE genes (eotaxin-3, MUC4, and CDH26) allowed to discriminate between EoE-like disease, EoE, and normal epithelium.
CONCLUSIONS: Patients suffering from 'EoE without eosinophilia' do not fulfill formally the diagnostic criteria for EoE. However, their clinical manifestation, immunohistology, and gene expression pattern, plus the fact that they bequeath EoE to their offspring, suggest a uniform underlying pathogenesis. Conventional EoE, with its prominent eosinophilia, therefore appears to be only one phenotype of a broader 'inflammatory dysphagia syndrome' spectrum. In this light, the role of the eosinophils, the definition of EoE, and its diagnostic criteria must likely be reconsidered.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  dysphagia; eotaxin; esophagus; inflammation

Mesh:

Substances:

Year:  2016        PMID: 26970242     DOI: 10.1111/all.12879

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  18 in total

1.  Another New Esophagitis: The Lymphocyte Gets Its Turn.

Authors:  David A Katzka
Journal:  Dig Dis Sci       Date:  2016-10       Impact factor: 3.199

2.  Gender-specific differences in the molecular signatures of adult Eosinophilic Oesophagitis.

Authors:  N Gonsalves; S Berdnikovs; H Schroeder; A Zalewski; P J Bryce
Journal:  Clin Exp Allergy       Date:  2017-07       Impact factor: 5.018

3.  Discovery and characterization of a novel humanized anti-IL-15 antibody and its relevance for the treatment of refractory celiac disease and eosinophilic esophagitis.

Authors:  Alain P Vicari; Alain M Schoepfer; Bertrand Meresse; Laurence Goffin; Olivier Léger; Soheila Josserand; Nicolas Guégan; Shida Yousefi; Alex Straumann; Nadine Cerf-Bensussan; Hans-Uwe Simon; Yolande Chvatchko
Journal:  MAbs       Date:  2017-06-05       Impact factor: 5.857

Review 4.  Genetics of eosinophilic esophagitis.

Authors:  L C Kottyan; M E Rothenberg
Journal:  Mucosal Immunol       Date:  2017-02-22       Impact factor: 7.313

Review 5.  Pathophysiology of Eosinophilic Esophagitis.

Authors:  Benjamin P Davis
Journal:  Clin Rev Allergy Immunol       Date:  2018-08       Impact factor: 8.667

6.  Medical algorithm: Diagnosis and treatment of eosinophilic esophagitis in adults.

Authors:  Thomas Greuter; Alex Straumann
Journal:  Allergy       Date:  2019-12-05       Impact factor: 13.146

7.  The Role of Allergy Testing in Eosinophilic Esophagitis.

Authors:  Adjoa Anyane-Yeboa; Wenfei Wang; Robert T Kavitt
Journal:  Gastroenterol Hepatol (N Y)       Date:  2018-08

8.  Mast Cell Infiltration Is Associated With Persistent Symptoms and Endoscopic Abnormalities Despite Resolution of Eosinophilia in Pediatric Eosinophilic Esophagitis.

Authors:  Scott M Bolton; Amir F Kagalwalla; Nicoleta C Arva; Ming-Yu Wang; Katie Amsden; Hector Melin-Aldana; Evan S Dellon; Paul J Bryce; Barry K Wershil; Joshua B Wechsler
Journal:  Am J Gastroenterol       Date:  2020-02       Impact factor: 12.045

Review 9.  Eosinophilic esophagitis-established facts and new horizons.

Authors:  Luc Biedermann; Alex Straumann; Thomas Greuter; Philipp Schreiner
Journal:  Semin Immunopathol       Date:  2021-06-07       Impact factor: 9.623

10.  Gastrointestinal Eosinophil Responses in a Longitudinal, Randomized Trial of Peanut Oral Immunotherapy.

Authors:  Benjamin L Wright; Nielsen Q Fernandez-Becker; Neeraja Kambham; Natasha Purington; Shu Cao; Dana Tupa; Wenming Zhang; Sayantani B Sindher; Matthew A Rank; Hirohito Kita; David A Katzka; Kelly P Shim; Bryan J Bunning; Alfred D Doyle; Elizabeth A Jacobsen; Mindy Tsai; Scott D Boyd; Monali Manohar; R Sharon Chinthrajah
Journal:  Clin Gastroenterol Hepatol       Date:  2020-05-17       Impact factor: 13.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.